Back

Three Plasmid Strategies, One Intermediate Convergence State: Lineage-Specific Resistance, Virulence Architecture in Dominant Indian Carbapenem-Resistant Klebsiella pneumoniae Clones

Kulkarni, S. M.; Jacob, J. J.; Rajendra, S.; S, P.; T, M. P.; Velmurugan, A.; Nelson, R.; Neeravi, A.; Balaji, L.; Gunasekaran, K.; Manesh, A.; Rajni, E.; Walia, K.; Veeraraghavan, B.

2026-06-24 microbiology
10.64898/2026.06.23.734134 bioRxiv
Show abstract

Carbapenem-resistant Klebsiella pneumoniae (CRKp) is a critical global healthcare threat driven by high-risk multidrug-resistant (MDR) clones that acquire hypervirulence genes. Although resistance-virulence co-occurrence is extensively documented, the plasmid-level mechanisms facilitating this convergence remain unclear. In this study, we utilized hybrid short- and long-read whole-genome sequencing of 376 clinical CRKp strains to define the evolutionary trajectories and structural plasmid dynamics of three predominant high-risk clones: ST147 (n=157), ST231 (n=108), and ST2096 (n=111). Carbapenemase genes were present in 90% of isolates, predominantly blaOXA-48-like and blaNDM-5 co-harbored with blaCTX-M-15. Virulence profiling indicated high aerobactin (iuc) prevalence (62.7%), while salmochelin and colibactin were undetected. Hypermucoviscosity occurred infrequently (6.6%) and was independent of rmpA/rmpA2, confirming a clear genotype-phenotype discordance. Comparative plasmid mapping revealed three distinct, lineage-specific plasmid configurations underlying this intermediate convergent pathotype: ST147 exhibited dynamic, mosaic hybrid IncFIB-IncHI1B plasmids; ST2096 showed structurally stabilized hybrids; and ST231 retained virulence and resistance determinants on separate, segregated plasmids. These findings show that convergence is regulated by multiple, clone-specific evolutionary routes rather than a single path, highlighting the critical need for more in-depth genomic surveillance capable of identifying convergent plasmids along with high-risk lineages

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Antimicrobial Agents and Chemotherapy
187 papers in training set
Top 0.2%
15.0%
2
Microbial Genomics
225 papers in training set
Top 0.3%
11.9%
3
The Journal of Infectious Diseases
202 papers in training set
Top 0.4%
6.7%
4
Frontiers in Microbiology
427 papers in training set
Top 2%
6.2%
5
Nature Communications
5641 papers in training set
Top 31%
4.3%
6
eLife
5828 papers in training set
Top 27%
4.3%
7
mSystems
394 papers in training set
Top 2%
3.4%
50% of probability mass above
8
mBio
833 papers in training set
Top 5%
3.2%
9
Genome Medicine
183 papers in training set
Top 1%
3.2%
10
Journal of Antimicrobial Chemotherapy
46 papers in training set
Top 0.3%
3.2%
11
Microbiology Spectrum
469 papers in training set
Top 5%
2.4%
12
npj Antimicrobials and Resistance
11 papers in training set
Top 0.1%
2.4%
13
Scientific Reports
3612 papers in training set
Top 48%
2.1%
14
JAC-Antimicrobial Resistance
14 papers in training set
Top 0.2%
2.1%
15
BMC Microbiology
49 papers in training set
Top 0.5%
2.1%
16
Journal of Infection
78 papers in training set
Top 0.5%
1.9%
17
Environmental Microbiology
133 papers in training set
Top 2%
1.7%
18
The Lancet Microbe
44 papers in training set
Top 0.4%
1.7%
19
PLOS ONE
5266 papers in training set
Top 55%
1.1%
20
MicrobiologyOpen
24 papers in training set
Top 0.3%
1.1%
21
mSphere
302 papers in training set
Top 6%
1.0%
22
Microbiology
65 papers in training set
Top 1%
1.0%
23
The Lancet Infectious Diseases
73 papers in training set
Top 1%
1.0%
24
Genomics
64 papers in training set
Top 2%
0.8%
25
PLOS Pathogens
820 papers in training set
Top 9%
0.8%
26
iScience
1154 papers in training set
Top 40%
0.6%
27
Applied and Environmental Microbiology
339 papers in training set
Top 5%
0.6%
28
Eurosurveillance
83 papers in training set
Top 1%
0.6%